216 related articles for article (PubMed ID: 18837945)
1. Clinical relevance of circulating nucleosomes in cancer.
Holdenrieder S; Nagel D; Schalhorn A; Heinemann V; Wilkowski R; von Pawel J; Raith H; Feldmann K; Kremer AE; Müller S; Geiger S; Hamann GF; Seidel D; Stieber P
Ann N Y Acad Sci; 2008 Aug; 1137():180-9. PubMed ID: 18837945
[TBL] [Abstract][Full Text] [Related]
2. Therapy control in oncology by circulating nucleosomes.
Holdenrieder S; Stieber P
Ann N Y Acad Sci; 2004 Jun; 1022():211-6. PubMed ID: 15251962
[TBL] [Abstract][Full Text] [Related]
3. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
Holdenrieder S; von Pawel J; Dankelmann E; Duell T; Faderl B; Markus A; Siakavara M; Wagner H; Feldmann K; Hoffmann H; Raith H; Nagel D; Stieber P
Clin Cancer Res; 2008 Dec; 14(23):7813-21. PubMed ID: 19047109
[TBL] [Abstract][Full Text] [Related]
4. Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy.
Holdenrieder S; Holubec L; Topolcan O; Finek J; Stieber P
Anticancer Res; 2005; 25(3A):1795-801. PubMed ID: 16033102
[TBL] [Abstract][Full Text] [Related]
5. Relevance of histone marks H3K9me3 and H4K20me3 in cancer.
Leszinski G; Gezer U; Siegele B; Stoetzer O; Holdenrieder S
Anticancer Res; 2012 May; 32(5):2199-205. PubMed ID: 22593510
[TBL] [Abstract][Full Text] [Related]
6. Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.
Stoetzer OJ; Wittwer C; Lehner J; Fahmueller YN; Kohles N; Fersching DM; Leszinski G; Roessner J; Holdenrieder S
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S217-24. PubMed ID: 22620489
[TBL] [Abstract][Full Text] [Related]
7. Circulating apoptotic markers in the management of non-small cell lung cancer.
Holdenrieder S; Stieber P
Cancer Biomark; 2010; 6(3-4):197-210. PubMed ID: 20660965
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of circulating nucleosomes.
Holdenrieder S; Stieber P
Crit Rev Clin Lab Sci; 2009; 46(1):1-24. PubMed ID: 19107649
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in serum of patients with solid tumours.
Holdenrieder S; Stieber P; Förg T; Kühl M; Schulz L; Busch M; Schalhorn A; Seidel D
Anticancer Res; 1999; 19(4A):2721-4. PubMed ID: 10470228
[TBL] [Abstract][Full Text] [Related]
10. Long-term stability of circulating nucleosomes in serum.
Holdenrieder S; Von Pawel J; Nagel D; Stieber P
Anticancer Res; 2010 May; 30(5):1613-5. PubMed ID: 20592350
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic relevance of circulating biomarkers in patients with lung cancer.
Molina R; Holdenrieder S; Auge JM; Schalhorn A; Hatz R; Stieber P
Cancer Biomark; 2010; 6(3-4):163-78. PubMed ID: 20660962
[TBL] [Abstract][Full Text] [Related]
12. Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
Taback B; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of total and lipid-bound sialic acid in malignancies].
Cylwik B; Chrostek L; Szmitkowski M
Pol Merkur Lekarski; 2005 Aug; 19(110):237-41. PubMed ID: 16245443
[TBL] [Abstract][Full Text] [Related]
14. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
[TBL] [Abstract][Full Text] [Related]
15. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
Gezer U; Holdenrieder S
In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
[TBL] [Abstract][Full Text] [Related]
16. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
[TBL] [Abstract][Full Text] [Related]
17. Nucleosomal DNA fragments in autoimmune diseases.
Holdenrieder S; Eichhorn P; Beuers U; Samtleben W; Schoenermarck U; Zachoval R; Nagel D; Stieber P
Ann N Y Acad Sci; 2006 Sep; 1075():318-27. PubMed ID: 17108227
[TBL] [Abstract][Full Text] [Related]
18. Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases.
Swarup V; Rajeswari MR
FEBS Lett; 2007 Mar; 581(5):795-9. PubMed ID: 17289032
[TBL] [Abstract][Full Text] [Related]
19. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.
Ellinger J; Albers P; Müller SC; von Ruecker A; Bastian PJ
BJU Int; 2009 Jul; 104(1):48-52. PubMed ID: 19154496
[TBL] [Abstract][Full Text] [Related]
20. Circulating nucleosomes in serum.
Holdenrieder S; Stieber P; Bodenmüller H; Busch M; Von Pawel J; Schalhorn A; Nagel D; Seidel D
Ann N Y Acad Sci; 2001 Sep; 945():93-102. PubMed ID: 11708501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
